Newsfeeds - Spark Newswire

5 minute read

Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday

Today, 9:12 PM

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

ADSE

5 minute read

77 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:12 PM

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners.

ACOR

5 minute read

81 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:12 PM

Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.

ALBO

12 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 9:12 PM

On Monday, 198 companies reached new 52-week lows.

ADV

2 minute read

Talaris Therapeutics Presents Data On COVID-19 Outcomes Among Kidney Transplant Patients Treated With FCR001; Co. Reports ‘No evidence of acute kidney injury or impaired renal function in FCR001-treated patients with COVID-19 infection’

By Benzinga Newsdesk

Today, 9:12 PM

Talaris Therapeutics, Inc. (NASDAQ:TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune

TALS

12 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 9:12 PM

On Friday, 209 companies set new 52-week lows.

ACHL

5 minute read

65 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:12 PM

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index.

AERC

2 minute read

Talaris Therapeutics Highlights Presentation Of Analysis Of HLA Mismatching In Phase 2 Trial In Living Donor Kidney Transplant

By Bill Haddad

Today, 9:12 PM

Talaris Therapeutics, Inc., (NASDAQ:TALS), a late-clinical stage cell therapy company, today presented a new analysis of HLA mismatching between donors and recipients participating in the Company's Phase 2 trial in

TALS

1 minute read

Talaris Therapeutics Q3 EPS $(0.32) Up From $(0.94) YoY

By Benzinga Newsdesk

Today, 9:12 PM

Talaris Therapeutics (NASDAQ:TALS) reported quarterly losses of $(0.32) per share. This is a 65.96 percent increase over losses of $(0.94) per share from the same period last year.

TALS

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 9:12 PM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT